Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning

Blood

Volumn 110, Issue 1, 2007, Pages 418-423

  Graves, Scott S ^a   Hogan, William ^a   Kuhr, Christian S ^a,b   Diaconescu, Razvan ^a   Harkey, Michael A ^a   Georges, George E ^a,b   Sale, George E ^a,b   Zellmer, Eustacia ^a   Baran, Szczepan ^a   Jochum, Christoph ^a   Stone, Brad ^c   Storb, Rainer ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CHIMERA; CONTROLLED STUDY; DOG; DONOR; ENGRAFTMENT; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNE FUNCTION TEST; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MIXED LEUKOCYTE CULTURE; MIXED LYMPHOCYTE REACTION; NONHUMAN; NONMYELOABLATIVE CONDITIONING; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; WHOLE BODY RADIATION;

EID: 34347395540     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2007-02-071282     Document Type: Article

References (24)

1. Mathé G, Amiel JL, Schwarzenberg L, Cattan A, Schneider M. Haematopoietic chimera in man after allogeneic (homologous) bone-marrow transplantation (Control of the secondary syndrome. Specific tolerance due to the chimerism). Br Med J. 1963;5373:1633-1635.
2. Barker JN, Krepski TP, Defor TE, Davies SM, Wagner JE, Weisdorf DJ. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant. 2002;8:257-260.
3. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339:1565-1577.
4. de La Selle V, Gluckman E, Bruley-Rosset M. Newborn blood can engraft adult mice without inducing graft-versus-host disease across non H-2 antigens. Blood. 1996;87:3977-3983.
5. Barker JN, Weisdorf DJ, Defor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005;105:1343-1347.
6. Lee EN, Lee J, Kim EY, et al. Tolerance induction through simultaneous double bone marrow transplantation with two-signal blockade. Immunol Lett. 2006;102:215-221.
7. Sandmaier BM, Fukuda T, Gooley T, Yu C, Santos EB, Storb R. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model. Exp Hematol. 2003;31:168-175.
8. Storb R, Yu C, Wagner JL, et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood. 1997;89:3048-3054.
9. Maloney DG, Molina AJ, Sahebi F, et al. Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma. Blood. 2003;102:3447-3454.
10. Woolfrey AE, Nash RA, Sanders JE, Ochs HD, Thomson B, Storb R. A nonmyeloablative regimen for induction of multi-lineage hematopoietic mixed donor-host chimerism in nonmalignant disorders [abstract]. Blood. 2000;98 (Part 1):784a, #3390.
11. McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001;97:3390-3400.
12. Maris MB, Niederwieser D, Sandmaier BM, et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood. 2003;102:2021-2030.
13. Wagner JL, Burnett RC, DeRose SA, Francisco LV, Storb R, Ostrander EA. Histocompatibility testing of dog families with highly polymorphic microsatellite markers. Transplantation. 1996;62:876-877.
14. Wagner JL, Works JD, Storb R. DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCRSSCP and sequencing (Brief Communication). Tissue Antigens. 1998;52:397-401.
15. n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation. 1994;58:701-706.
16. Hilgendorf I, Weirich V, Zeng L, et al. Canine haematopoietic chimerism analyses by semi-quantitative fluorescence detection of variable number of tandem repeat polymorphism. Vet Res Commun. 2005;29:103-110.
17. Kuhr CS, Allen MD, Junghanss C, et al. Tolerance to vascularized kidney grafts in canine mixed hematopoietic chimeras. Transplantation. 2002;73:1487-1493.
18. Junghanss C, Takatu A, Little M-T, et al. Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras. Transplantation. 2003;75:268-274.
19. Raff RF, Deeg HJ, Farewell VT, DeRose S, Storb R. The canine major histocompatibility complex. Population study of DLA-D alleles using a panel of homozygous typing cells. Tissue Antigens. 1983;21:360-373.
20. Storb R, Raff RF, Graham T, et al. Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation. Biol Blood Marrow Transplant. 1999;5:155-161.
21. Taranova AG, Georges GE, Yunusov M, Storb RF, Nash RA. Breaking tolerance in stable mixed chimeric dogs with low-dose TBI and donor or recipient lymphocyte infusion [abstract]. Blood. 2003;102 (Part 1):76a, #256.
22. Kang HJ, Kho SH, Jang MK, Lee SH, Shin HY, Ahn HS. Early engraftment kinetics of two units cord blood transplantation. Bone Marrow Transplant. 2006;38:197-201.
23. Zaucha JM, Zellmer E, Georges G, et al. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required. Biol Blood Marrow Transplant. 2001;7:613-619.
24. Storb R, Yu C, Barnett T, et al. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation. Blood. 1999;94:1131-1136.